Lista de obras -

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy

artículo científico publicado en 2014

Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop

artículo científico publicado en 2005

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice

artículo científico publicado en 2014

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

artículo científico publicado en 2014

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.

artículo científico publicado en 2017

Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy

artículo científico publicado en 2015

Evolution of the prevalence of HCV infection and HCV genotype distribution in HIV-infected patients in Italy between 1997 and 2015.

artículo científico

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

artículo científico

Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice

artículo científico publicado en 2016

Low rate of virological failure and maintenance of susceptibility to HIV‐1 protease inhibitors with first‐line lopinavir/ritonavir‐based antiretroviral treatment in clinical practice ⬇️

artículo científico publicado el 1 de diciembre de 2010

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

artículo científico

Optimizing HIV therapy. A consensus project on differences between cytidine analogues and regime compactness

artículo científico publicado en 2014

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

article

Treating HIV disease: back to the patient?

artículo científico publicado en 2016

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

artículo científico publicado en 2009

Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy

artículo científico publicado en 2014

Lista de obras de

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy

Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.

Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy

Evolution of the prevalence of HCV infection and HCV genotype distribution in HIV-infected patients in Italy between 1997 and 2015.

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology

Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice

Low rate of virological failure and maintenance of susceptibility to HIV‐1 protease inhibitors with first‐line lopinavir/ritonavir‐based antiretroviral treatment in clinical practice ⬇️

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

Optimizing HIV therapy. A consensus project on differences between cytidine analogues and regime compactness

Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment

Treating HIV disease: back to the patient?

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy